Newsletter Subject

New Facebook Page for an AD Treatment

From

caring.com

Email Address

offers@caring.com

Sent On

Thu, Oct 26, 2017 03:06 PM

Email Preheader Text

Learn about a treatment for moderate Alzheimer's From Caring.com: Below is a special message on beha

Learn about a treatment for moderate Alzheimer's From Caring.com: Below is a special message on behalf of our partners, which we hope you'll find valuable. [Prescribing Information]( [Important Risk Information]( [hero image]( Dear Caregiver, NAMZARIC (memantine and donepezil hydrochlorides) is a prescription medicine approved to treat moderate to severe Alzheimer’s disease (AD) in patients who are taking donepezil hydrochloride 10 mg, the active ingredient in Aricept®. As part of our ongoing commitment to those affected by moderate Alzheimer's disease, we have created a new Facebook page to ensure we are continuing the conversation with caregivers like you across different platforms. Don't forget to like the page for more information about NAMZARIC. IMPORTANT RISK INFORMATION NAMZARIC should not be taken by anyone who: has an allergy to memantine HCl, donepezil HCl, medicines that contain piperidines, or any of the ingredients in NAMZARIC. Please see additional [Important Risk Information below](#information). Resources to Assist Caregivers [Advertisement][Advertisement][Advertisement][Advertisement][Advertisement][Advertisement][Advertisement][Advertisement][Advertisement][Advertisement][Advertisement][Advertisement][Advertisement][Advertisement][Advertisement] In addition to the new Facebook page, we provide more resources at NAMZARIC.com intended to support caregivers of patients with AD: [Interactive Appointment Checklist]( [arrow]( [Patient Education Brochure]( [questions]( [Sample Questions to Ask Your Loved One's Healthcare Provider]( [info]( [Additional Support for Caregivers and Family]( There is no evidence that NAMZARIC prevents or slows the underlying disease process in patients with Alzheimer’s disease. IMPORTANT RISK INFORMATION (continued) Before taking NAMZARIC, tell the doctor about all of the patient’s medical conditions, including: • heart problems including an irregular, slow, or fast heartbeat • asthma or lung problems • seizures • stomach ulcers • bladder, kidney, or liver problems • any surgical, dental, or other medical procedures scheduled when anesthesia may be used Tell the doctor about all the medicines the patient takes, including prescription and over-the-counter medicines, vitamins, and herbal supplements. What are the possible side effects of NAMZARIC? NAMZARIC may cause serious side effects, including: • muscle problems in patients given anesthesia • slow heartbeat and fainting. This happens more often in people with heart problems. Call the doctor right away if the patient faints while taking NAMZARIC. • more stomach acid. This raises the chance of ulcers and bleeding especially when taking NAMZARIC. The risk is higher for patients who have had ulcers, or take aspirin or other NSAIDs. • nausea and vomiting • difficulty passing urine • seizures • worsening of lung problems in people with asthma or other lung disease The most common side effects of memantine HCl include: headache, diarrhea, and dizziness. The most common side effects of donepezil HCl include: diarrhea, not wanting to eat (anorexia), and bruising. These are not all the possible side effects of NAMZARIC. Please see full [Prescribing Information]( including Patient Information. For more information about NAMZARIC, please visit [NAMZARIC.com]( or call Allergan Customer Relations and Medical Affairs toll-free at 1.800.678.1605. PLEASE NOTE: DO NOT REPLY TO THIS EMAIL. Emails sent to this account will not be read. If you would prefer not to receive further messages from this sender, please [click here]( and confirm your request. We respect your privacy. See our [Privacy Statement](. [Allergan logo]( Allergan USA, Inc. Morris Corporate Center III 400 Interpace Parkway Parsippany, NJ 07054 Allergan® and its design are trademarks of Allergan, Inc. Namzaric® and its design are trademarks of Merz Pharma GmbH & Co. KGaA. © 2017 Allergan. All rights reserved. NMZ111327 10/17 This message was intended for {EMAIL}. You received this e-mail because our records indicate that you're willing to receive offers from Caring.com and our partners. If you no longer wish to receive such offers, please [unsubscribe](. All content © 2007-2017 Caring, Inc., 2600 S. El Camino Real, Suite 300, San Mateo, CA 94403. All rights reserved. - - - - - - - - - - - - - - - - - - - - - - - -

Marketing emails from caring.com

View More
Sent On

12/03/2019

Sent On

17/10/2018

Sent On

12/04/2018

Sent On

14/03/2018

Sent On

16/01/2018

Sent On

28/12/2017

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.